(thirdQuint)Corticosteroids for Cancer Pain.

 Patients are required to use strong opioids before entering the study.

 Weak opioids are allowed if patients have short acting strong opioids as rescue-medication.

 The scheduled opioids shall be stable last 48 hours before entering the study and will be kept stable during the study period.

 Patients may use as much short acting rescue-medication as they require.

 No other analgesic medication should be started during the study period.

 The study is a multicentre trial.

 Patients will be randomized according to 1.

 study centre (No 1-5) and 2.

 pain mechanism: skeletal metastases (yes/no).

 Patients are evaluated Day 0 and Day 7 by palliative care physician.

 Patients will be contacted by phone Day 1-6 and will fill in questionnaire regarding symptoms and analgesic usage.

 Patients will be contacted Day 14 and 21 to fill in questionnaires regarding symptoms, quality of life and side effects.

.

 Corticosteroids for Cancer Pain@highlight

Study hypothesis: corticosteroids are effective for pain in cancer patients.

 We will perform a double-blind, randomized, placebo-controlled multicentre trial evaluating the effect of Methylprednisolone 16 mg twice daily in cancer patients with pain (average pain last 24 hrs NRS > 4 (Numerical rating scale, 0 No pain, 10 worst pain).

